Ascend Laboratories LLC is recalling 3,072 bottles of Tamsulosin Hydrochloride Capsules, USP (0.4 mg), a prescription medication used to treat symptoms of an enlarged prostate. This recall was initiated because the medication failed stability testing, specifically showing "high out-of-specification" dissolution results. This means the drug may release into the body too quickly or in an inconsistent manner, which could affect how well the treatment works or lead to unexpected side effects. These capsules were distributed nationwide in the United States and Puerto Rico in 500-count bottles.
When a drug fails dissolution testing, it may not dissolve at the rate required for safe and effective treatment. This can lead to the medication being absorbed by the body too rapidly, potentially causing an increased risk of side effects or a lack of therapeutic effect for the patient's condition.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.